| SC 13G/A | 2016-02-10 | BlackRock Inc. | Ophthotech Corp. | 1,740,810 | 4.9% | EDGAR |
| SC 13G | 2016-01-28 | BlackRock Inc. | Ophthotech Corp. | 1,758,622 | 5.0% | EDGAR |
| SC 13D/A | 2015-06-02 | SVLSF IV, LLC | Ophthotech Corp. | 1,455,017 | 4.2% | EDGAR |
| SC 13D/A | 2015-04-03 | SVLSF IV, LLC | Ophthotech Corp. | 1,798,906 | 5.3% | EDGAR |
| SC 13D/A | 2015-03-11 | Novo A/S | Ophthotech Corp. | 4,910,489 | 14.4% | EDGAR |
| SC 13G/A | 2015-02-17 | JHL Capital Group LLC | Ophthotech Corp. | 3,265,000 | 9.7% | EDGAR |
| SC 13G/A | 2015-02-13 | FMR LLC | Ophthotech Corp. | 5,047,678 | 15.0% | EDGAR |
| SC 13D/A | 2015-01-06 | SVLSF IV, LLC | Ophthotech Corp. | 2,367,338 | 7.0% | EDGAR |
| SC 13D/A | 2014-11-18 | Novo A/S | Ophthotech Corp. | 5,915,489 | 17.6% | EDGAR |
| SC 13D/A | 2014-10-28 | HBM Healthcare Investments (Cayman) Ltd. | Ophthotech Corp. | 1,611,036 | 4.8% | EDGAR |
| SC 13D/A | 2014-06-30 | Clarus Lifesciences II, L.P. | Ophthotech Corp. | - | - | EDGAR |
| SC 13D/A | 2014-06-09 | HBM Healthcare Investments (Cayman) Ltd. | Ophthotech Corp. | 2,623,318 | 7.9% | EDGAR |
| SC 13D/A | 2014-06-05 | SVLSF IV, LLC | Ophthotech Corp. | 3,054,458 | 9.2% | EDGAR |
| SC 13D/A | 2014-05-15 | HBM Healthcare Investments (Cayman) Ltd. | Ophthotech Corp. | 3,153,572 | 9.4% | EDGAR |
| SC 13G/A | 2014-05-12 | FMR LLC | Ophthotech Corp. | 3,576,951 | 10.7% | EDGAR |
| SC 13G | 2014-04-14 | JHL Capital Group LLC | Ophthotech Corp. | 1,780,000 | 5.3% | EDGAR |
| SC 13D/A | 2014-02-26 | Clarus Lifesciences II, L.P. | Ophthotech Corp. | 3,054,744 | 9.2% | EDGAR |
| SC 13D/A | 2014-02-24 | Novo A/S | Ophthotech Corp. | 6,910,489 | 20.7% | EDGAR |
| SC 13D/A | 2014-02-19 | SVLSF IV, LLC | Ophthotech Corp. | 5,079,458 | 15.2% | EDGAR |
| SC 13G | 2014-02-14 | FMR LLC | Ophthotech Corp. | 1,878,763 | 6.2% | EDGAR |